Astria Therapeutics, Inc.(NASDAQ:ATXS) 
Catabasis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. The company's lead product candidate is QLS-215, a monoclonal antibody inhibitor of plasma kallikrein that is in preclinical development fo...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.93
H 5.07
L 4.62
C 4.66
V 335,595
10EMA 4.66
20EMA 4.66
60EMA 4.66
120EMA 4.66
250EMA 4.66